Jill David, Reginald Chounoune, Alene Wright, Abdul Waheed and Frederick D Cason*
Department of General Surgery, San Joaquin General Hospital, USA
*Corresponding Author: Frederick D Cason, Department of General Surgery, San Joaquin General Hospital, USA.
Received: June 12, 2020; Published: June 22, 2020
Angiomyolipomas are the most common clonal mesenchymal tumors of the kidney. Metastatic renal epithelioid angiomyolipomas (MREA) are a less common variant that are found to have malignant potential. We present a case of a 59-year old female diagnosed and treated for MREA which was initially thought to be a benign renal mass. The patient was being followed with serial abdominal imaging which showed subsequent development of two large abdominal masses. Appropriate surgical intervention was performed, the patient tolerated the procedure with minimal complications, and the post-operative microscopic evaluation of biopsied specimens confirmed the diagnosis of MREA. Unlike commonly benign renal angiomyolipomas, MREA is a highly aggressive lesion. It is imperative for clinicians to identify and differentiate this life-threatening lesion from renal cell carcinoma (RCC). A multimodality treatment approach including resection of tumor and adjuvant therapy may provide optimum treatment for MREA.
Keywords: Renal Cell Carcinoma (RCC); Metastatic Renal Epithelioid Angiomyolipomas (MREA); Carcinoembryonic Antigen (CEA)
Citation: Frederick D Cason., et al. “Metastatic Renal Epithelioid Angiomyolipoma: An Interesting and Rare Case Report”Acta Scientific Gastrointestinal Disorders 3.7 (2020): 09-12.
Copyright: © 2020 Frederick D Cason., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.